ESMO 2017 | Grant McArthur on the 3 positive melanoma trials presented at the ESMO 2017 Congress

Grant McArthur

We spoke to Grant McArthur during the ESMO 2017 Congress in Madrid, Spain to get his take on the exciting new data presented in melanoma during the meeting. As well as commenting on the data of the COMBI-AD, BRIM8 and CheckMate23 trials, he also emphasizes how well tolerated some of these medicines have been.

Share this video